Comparison of poloxamer-and chitosan-based thermally sensitive gels for the treatment of vaginal mucositis

Drug Development and Industrial Pharmacy

Volumn 40, Issue 3, 2014, Pages 352-360

  Rossi, Silvia ^a   Ferrari, Franca ^a   Bonferoni, Maria Cristina ^a   Sandri, Giuseppina ^a   Faccendini, Angela ^a   Puccio, Antonella ^a   Caramella, Carla ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chitosan lactate glycerophosphate mixture; in situ gelling system; Mucoadhesion; Poloxamer chitosan lactate mixtures; Vaginal administration; Wound healing properties

Indexed keywords

AMOXICILLIN; CHITOSAN; GLYCEROPHOSPHATE; LACTIC ACID; POLOXAMER;

ANTIMICROBIAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; DRUG RELEASE; ELASTICITY; FLOW KINETICS; GEL; GELATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUCOADHESION; MUCOSA INFLAMMATION; OSCILLATION; SHEAR RATE; VAGINA DISCHARGE; VAGINA DISEASE; VAGINAL MUCOSITIS; VISCOMETRY; VISCOSITY; WOUND HEALING;

ADHESIVENESS; AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CHITOSAN; DRUG CARRIERS; ELASTICITY; FEMALE; GASTRIC MUCINS; GELS; GLYCEROPHOSPHATES; HUMANS; POLOXAMER; SWINE; TEMPERATURE; VAGINITIS;

EID: 84891816032     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.762654     Document Type: Article

References (35)

1. Byeongmoon J, Sung Wan K, You Han B. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37-51.
2. Ruel-Gariépy E, Leroux J-C. In situ-forming hydrogels-review of temperature-sensitive systems. Eur J Pharm Biopharm 2004;58:409-26.
3. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23:2709-28.
4. Koffi AA, Agnely F, Besnard M, et al. In vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in children. Eur J Pharm Biopharm 2008;69:167-75.
5. Sandri G, Bonferoni MC, Ferrari F, et al. An in situ gelling buccal spray containing platelet lysate for the treatment of oral mucositis. Curr Drug Discov Technol 2011;8:277-85.
6. Escobar-Chavez JJ, Lopez-Cervantes M, Näik A, et al. Applications of thermoreversible Pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharmaceut Sci 2006;9:339-58.
7. Liu Y, Lu W-L, Wang J-C, et al. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic® F127 hydrogel for subcutaneous administration: in vitro and in vivo characterization. J Control Rel 2007;117:387-95.
8. Yang Y, Wang J, Zhang X, et al. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel. J Control Rel 2009;135:175-82.
9. Kumar KJ, Jayachandran E, Srinivas GM, et al. A novel thermo-sensitive sol-gel reversible buccal adhesive property of Fluconazole in situ gel for oral thrush. J Biomed Sci Res 2010;2:92-101.
10. Xuan J-J, Yan YD, Oh DH, et al. Development of thermo-sensitive injectable hydrogel with sustained release of doxorubicin: rheological characterization and in vivo evaluation in rats. Drug Deliv 2011;18:305-11.
11. Lin HR, Sung KC, Vong WJ. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine. Biomacromolecules 2004;6:2358-65.
12. Qi H, Chen W, Huang C, et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 2007;1:178-87.
13. Mayol L, Quaglia F, Borzacchiello A, et al. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm 2008;70:199-206.
14. Aka-Any-Grah A, Bouchemal K, Koffi A, et al. Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids. Eur J Pharm Biopharm 2010;76:296-303.
15. Gratieri T, Gelfuso Martins M, de Freitas O, et al. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel. Eur J Pharm Biopharm 2011;79:320-7.
16. Chenite A, Chaput C, Wang D, et al. Novel injectable neutral solution of chitosan form biodegradable gel in situ. Biomaterials 2000;2:2155-61.
17. Chenite A, Buschmann MD, Wang D, et al. Rheological characterization of thermogelling chitosan/glycerophosphate solutions. Carboydr Polym 2001;46:39-47.
18. Ganguly S, Dash AK A novel in situ gel for sustained drug delivery and targeting. Int J Pharm 2004;276:83-92.
19. Ruel-Gariépy E, Shive M, Bichar A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 2004;57:53-63.
20. Lavertu M, Filion D, Buschmann MD. Heat-induced transfer of protons from chitosan to glycerol phosphate produces chitosan precipitation and gelation. Biomacromolecules 2008;9:640-50.
21. Rossi S, Marciello M, Bonferoni M C, et al. Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis. Eur J Pharm Biopharm 2010;74:248-54.
22. Zhishen J, Dongfeng S, Weiliang X. Synthesis and antibacterial activities of quaternary ammonium salt of chitosan. Carbohydr Res 2001;333:1-6.
23. Rossi S, Marciello M, Sandri G, et al. Wound dressings based on chitosans and hyaluronic acid for the release of chlorhexidine diacetate in skin ulcer therapy. Pharm Dev Technol 2007;12: 415-22.
24. Muzzarelli RAA. Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone. Carbohydr Polym 2009;76:167-82.
25. Abramov Y, Golden B, Sullivan M, et al. Histologic characterization of vaginal versus abdominal surgical wound healing in a rabbit model. Wound Rep Reg 2007;15:80-6.
26. Howling GI, Dettmar PW, Goddard PA, et al. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro. Biomaterials 2001;22:2959-66.
27. Choi H-G, Jung J-H, Ryu J-M, et al. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm 1998;165:33-44.
28. Ponchel G, Touchard F, Duchene D, Peppas NA. Bioadhesive analysis of controlled release systems. I. Fracture and interpenetra-tion analysis in poly(acrylic acid)-containing systems. J Control Rel 1987;5:129-41.
29. Duchene D, Ponchel G, Wouessidjewe D, et al. Méthodes d'évalu-ation de la bioadhésion et facteurs influants. S.T.P. Pharma 1998;4:688-97.
30. Owen DH, Katz DF. A vaginal fluid stimulant. Contraception 1999;59:91-5.
31. Chang JY, Oh Y-K, Choi H, et al. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int J Pharm 2002;241:155-63.
32. Sandri G, Bonferoni MC, Rossi S, et al. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Eur J Pharm Biopharm 2007;65:68-77.
33. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. In: Approved Standard Seventh Edition. Clinical and Laboratory Standards Institute document M7-A7. Wayne (PA): Clinical and Laboratory Standards Institute; 2006:1-49.
34. Bonferoni MC, Rossi S, Ferrari F, Caramella C. A modified Franz diffusion cell for simultaneous assessment of mucoadhesive gels. Pharm Dev Technol 1999;4:45-53.
35. Puccio A, Ferrari F, Rossi S, et al. Comparison of functional and biological properties of chitosan and hyaluronic acid, to be used for the treatment of mucositis in cancer patients. J Drug Del Sci Tech 2011;21:241-7.